JBS vs PPC: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. JBS and PPC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined JBS and PPC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

JBS processes and sells animal protein at a scale nobody else matches: beef, pork, chicken and lamb, slaughtered and packed in more than a dozen countries and shipped to roughly 180. The operating structure is really six businesses under one roof. JBS Beef North America is the largest by revenue (about $7.2 billion in the first quarter of 2026), followed by Pilgrim's Pride, the US chicken company JBS controls with a stake of about ~82% and which trades separately as PPC, then JBS Brazil, Seara (branded and prepared foods in Brazil, the highest-margin unit), JBS USA Pork and JBS Australia. Brands include Friboi, Swift, Seara, Moy Park, Primo and Pilgrim's. Revenue was about $86.2 billion in 2025 and roughly ~$91 billion over the trailing twelve months, which makes JBS one of the largest food companies on earth by sales and one of the smallest by market value relative to those sales, at around ~$14 billion.

Full JBS guide

Pilgrim's Pride Corporation is one of the largest poultry producers in the world, raising, processing, and marketing fresh, frozen, and prepared chicken (plus some pork in Europe) across three reporting regions: the United States, Mexico, and Europe. The US is its biggest segment, and Europe operates well-known brands such as Moy Park, while its Just BARE and Pilgrim's branded lines anchor a push into higher-value retail and prepared foods. Because most of its volume is commodity chicken sold into wholesale, foodservice, and retail channels, results are driven heavily by chicken cutout prices, the cost of feed inputs like corn and soybean meal, and plant utilization rather than by any single product.

Full PPC guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• JBS drivers: Protein and geographic diversification as a built-in hedge; A cattle cycle that mathematically has to turn.
• PPC drivers: Chicken cycle and cutout prices; Feed costs and operating efficiency.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: This is a commodity processor, so margins are set by the spread between livestock costs and meat prices, and JBS controls neither. For PPC, the dominant risk is commodity cyclicality: revenue and margins swing with chicken cutout prices, feed costs, and demand, and Q1 2026 already showed margins can halve year over year when US pricing softens and plants face downtime.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick JBS if you believe its drivers more; PPC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the JBS and PPC guides.

JBS. JBS screens as one of the cheapest large food companies in the world on earnings and almost absurdly cheap on sales, but both readings need context. The trailing multiple sits on earnings that absorb a loss-making US beef unit and one-off antitrust settlements, so it is neither a peak nor a clean trough number, and the low sales ratio reflects packing economics where a 5-6% EBITDA margin is a normal outcome rather than a distressed one. The ~7.6% yield rests on a single US$1.00 payment against trailing EPS of about ~$1.07. As of mid-October 2026, 15 covering analysts carried an average twelve-month target near ~$18.52, and the November 9 third-quarter report plus the outcome of the Pilgrim's Pride proposal are the next tests.

PPC. Figures are approximate and tied to the asOf date; verify live numbers before acting. The trailing P/E has risen to about 13 from under 8 in mid-year because earnings fell faster than the share price, a reminder that for a cyclical protein producer the multiple moves with where the cycle sits. The pending JBS proposal now anchors much of the valuation debate, and with JBS holding roughly 80% or more of the shares, the small public float can affect liquidity and how the market values the minority stake; Q3 results are due October 28, 2026.

Headline figures (approximate, October 2026): JBS shows revenue (ttm) ~$91 billion, after ~$86.2 billion in FY2025 (+11.7%), q2 2026 results Record ~$24 billion net sales, ~$1.43 billion adjusted EBITDA (~6% IFRS margin), adjusted EPS ~$0.20, reported net loss ~$102 million, net income / eps (ttm) ~$1.1 billion, ~$1.07 per share, price / market cap ~$13.12 a share (October 16, 2026), ~$14 billion, 52-week range ~$10.61 to ~$18.65; PPC shows revenue (ttm) ~$18.4 billion (Q2 2026 ~$4.63 billion, down ~3% year over year), net income ~$546 million TTM; Q2 2026 ~$13 million, eps ~$2.29 trailing; Q2 2026 $0.64 vs ~$0.66 expected, margins Gross ~9.7%, operating ~1.6% (latest quarter basis per Yahoo).

JBS and PPC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined JBS and PPC exposure against your real portfolio. It is not an investment adviser.